Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioners' oral contraception study

British Medical Journal

Volumn 335, Issue 7621, 2007, Pages 651-654

  Hannaford, Philip C ^a   Selvaraj, Sivasubramaniam ^b   Elliott, Alison M ^a   Angus, Valerie ^a   Iversen, Lisa ^a   Lee, Amanda J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Centre for Rural Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CENTRAL NERVOUS SYSTEM; CLINICAL OBSERVATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; GALLBLADDER CANCER; GROUPS BY AGE; GYNECOLOGIC CANCER; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS TUMOR; LARGE INTESTINE CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; OVARY CANCER; PARITY; PHYSICIAN; PRIORITY JOURNAL; RECTUM CANCER; RISK BENEFIT ANALYSIS; RISK FACTOR; SMOKING; SOCIAL CLASS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; CONTRACEPTIVES, ORAL; FAMILY PRACTICE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 35148842531     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39289.649410.55     Document Type: Article

References (13)

1. Cogliano V, Grasse Y, Baan R, Straif K, Secretan B, El Ghissassi F. Carcinogenicity of combined oral oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 2005;6:552-3.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
3. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003;361:1159-67.
4. La Vecchia C, Alberti A, Franceschi S, Tavani A. Oral contraceptives and cancer: an update. Drug Saf 2001;24:741-54.
5. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Francheschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001;81:722-7.
6. Royal College of General Practitioners. Oral contraceptives and health. London: Pitman Medical, 1974.
7. Rosner B. Fundamentals of biostatistics. California: Duxbury Press, 2000.
8. Dickinson HO, Salotti JA, Birch PJ, Reid MM, Malcolm A, Parker L. How complete and accurate are cancer registrations notified by the National Health Service Cancer Register for England and Wales? J Epidemiol Community Health 2001;55:414-22.
9. Beral V, Hermon C, Kay C, Hannaford PC, Darby S, Reeves G. Mortality in relation to method of follow-up in the Royal College of General Practitioners' oral contraception study. In: Hannaford PC, Webb AMC, eds. Evidence-guided prescribing of the pill. London: Parthenon, 1996:327-39.
10. Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort, 1968-2004. Br J Cancer 2006;95:385-9.
11. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' oral contraception study. Lancet 1988;2:1331-5.
12. Weiderpass E, Adami H-O, Baron JA, Magnusson C, Lindgren A, Persson I. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control 1999;10:277-84.
13. Royar J, Becher H, Chang-Claude J. Low-dose oral contraceptives: protective effect on ovarian cancer risk. Int J Cancer 2001;95:370-4.